Expression of IL-6 is associated with increased HO-1 expression in multiple myeloma (MM) and high levels of both (IL-6 and HO-1) can be used as a marker of poor prognosis in MM [49]. The gene discussed is HMOX1; the disease is plasma cell myeloma.